Home » Stocks » Phibro Animal Health

Phibro Animal Health Corporation (PAHC)

Stock Price: $20.40 USD -0.15 (-0.73%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 825.25M
Revenue (ttm) 818.35M
Net Income (ttm) 36.71M
Shares Out 20.29M
EPS (ttm) 0.91
PE Ratio 22.42
Forward PE 20.33
Dividend $0.48
Dividend Yield 2.35%

Stock Quote

Trading Day Aug 7, 2020
Last Price $20.40
Previous Close $20.55
Change ($) -0.15
Change (%) -0.73%
Day's Open 20.57
Day's Range 20.12 - 20.77
Day's Volume 155,831
52-Week Range 16.87 - 33.97

More Stats

Market Cap 825.25M
Enterprise Value 1.11B
Earnings Date (est) Aug 26, 2020
Ex-Dividend Date Jun 2, 2020
Shares Outstanding 20.29M
Float 20.21M
EPS (basic) 0.89
EPS (diluted) 0.91
FCF / Share 0.90
Dividend $0.48
Dividend Yield 2.35%
Earnings Yield 4.46%
FCF Yield 4.39%
Payout Ratio 53.90%
Shares Short 673,737
Short Ratio 6.39
Short % of Float 4.31%
Beta 0.43
PE Ratio 22.42
Forward PE 20.33
P/FCF Ratio 22.76
PS Ratio 1.01
PB Ratio 4.94
Revenue 818.35M
Operating Income 63.17M
Net Income 36.71M
Free Cash Flow 36.26M
Net Cash -285.29M
Net Cash / Share -7.05
Gross Margin 32.34%
Operating Margin 7.72%
Profit Margin 4.50%
FCF Margin 4.43%
ROA 5.86%
ROE 17.95%
ROIC 7.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 1
Overweight 0
Hold 3
Underweight 1
Sell 1

Analyst Consensus: Hold

Price Target

$22.00*
(7.84% upside)
Low
20.0
Current: $20.40
High
25.0
Target: 22.00
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014201320122011
Revenue828820764752749692653654618
Revenue Growth0.98%7.29%1.7%0.39%8.19%5.93%-0.15%5.78%-
Gross Profit265267248239233204179164147
Operating Income83.2398.9397.9385.7487.6763.7956.7349.3341.24
Net Income54.7164.8864.6282.7360.28-3.1324.896.98-12.92
Shares Outstanding40.4140.1839.5239.2538.9732.1930.4630.4668.91
Earnings Per Share1.351.611.612.071.51-0.100.820.23-0.19
EPS Growth-16.15%0%-22.22%37.09%--256.52%--
Dividend Per Share0.460.400.400.400.40----
Dividend Growth15%0%0%0%-----
Operating Cash Flow47.1770.0198.3937.2268.70-0.711.4431.99-4.68
Capital Expenditures-29.89-18.55-20.88-36.35-20.06-19.85-19.95-14.82-21.64
Free Cash Flow17.2851.4677.510.8748.65-20.56-18.5117.16-26.32
Cash & Equivalents81.5779.1756.0833.6129.2211.8227.3753.900.00
Total Debt326312313350290289366350-
Net Cash / Debt-245-233-257-317-260-278-338-2960.00
Assets727672623608493472474441-
Liabilities511487472517464457543529-
Book Value21618515190.4829.6315.15-68.94-88.23-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Phibro Animal Health Corporation
Country United States
Employees 1,600
CEO Jack C. Bendheim

Stock Information

Ticker Symbol PAHC
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: PAHC
IPO Date April 11, 2014

Description

Phibro Animal Health Corporation manufactures and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It also operates in Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. The company is headquartered in Teaneck, New Jersey. Phibro Animal Health Corporation is a subsidiary of BFI Co., LLC.